Skip to main content
. Author manuscript; available in PMC: 2015 Feb 16.
Published in final edited form as: Oncogene. 2013 Sep 16;33(29):3776–3783. doi: 10.1038/onc.2013.359

Figure 5.

Figure 5

RET protein expression by IHC. RET staining in fatal adenocarcinoma was typically much less intense in ASCL1 (a) than in ASCL1+ (b) tumors. (c) Co-IHC of ASCL1 (nuclear brown staining) and RET (cytoplasmic red staining) identified areas with overlapping expression of the two proteins. (d) KM plot of 14 ASCL1+ AD samples indicates a significant association with OS (P = 0.05). (e) When samples were not stratified by the ASCL1 expression, RET IHC was not significant in predicting OS.